U.S. Oil and Gas Stock News

BridgeBio Pharma recently reported strong late-stage clinical data for acoramidis in transthyretin amyloid cardiomyopathy and encaleret in autosomal dominant hypocalcemia type 1, alongside submitting a New Drug Application to the FDA for encaleret. These advances suggest BridgeBio is moving beyond a single-product story, with encaleret potentially adding a second rare-disease franchise alongside Attruby. We’ll now examine how the positive encaleret NDA submission and ADH1 data could reshape...

Why Arcos Dorados' Latest Earnings Matter for Investors Arcos Dorados Holdings (ARCO) reported first quarter 2026 revenue of US$1,215.96 million and net income of US$36.14 million, compared with US$1,076.59 million and US$13.93 million a year earlier. Basic earnings per share from continuing operations reached US$0.17, up from US$0.07 in the prior year period, giving investors fresh data on how the McDonald’s franchise operator uses its Latin American footprint to generate profit. See our...

Old Republic International (ORI) has just paired a fresh fixed income move with a cash payout to shareholders, completing a US$699.818 million senior unsecured notes offering and affirming a quarterly dividend of US$0.315 per share. See our latest analysis for Old Republic International. Despite the fresh US$699.818 million notes and the steady dividend signal, Old Republic International’s share price has eased in recent months, with a 30 day share price return decline of 2.57% and a year to...

Recent performance snapshot and business context Oculis Holding (NasdaqGM:OCS) has attracted fresh attention after recent trading, with the stock last closing at $29.49. Investors are weighing this price against the company’s clinical-stage pipeline and current financial profile. See our latest analysis for Oculis Holding. At $29.49, the stock has pulled back around 4.9% over the last day but still sits on a year-to-date share price return of about 47%, alongside a 1-year total shareholder...

Roblox (RBLX) has put a new US$3b share repurchase program on the table, even as it trims full year revenue guidance and faces legal questions about past user metrics and scrutiny related to platform safety. See our latest analysis for Roblox. The share repurchase announcement comes after a sharp reset in expectations, with the stock down 40.5% year to date on a share price basis and the 1 year total shareholder return declining 41.5%, while the 3 year total shareholder return remains...

Earlier in May, C.H. Robinson Worldwide received a bullish analyst upgrade from Jefferies, which highlighted the company’s early-stage technology and productivity transformation and its strong balance sheet as it prepares for potential industry consolidation in freight brokerage. Management’s focus on Lean practices, AI-driven productivity gains, and readiness to act as a consolidator amid regulatory changes is reshaping how investors view C.H. Robinson’s role in a changing logistics...

Recent share performance and business snapshot CareDx (CDNA) has drawn investor attention after recent share price moves, with the stock last closing at $21.63 and recording mixed short term returns over the past week, month and past 3 months. The company focuses on transplant related diagnostics and software, with US$412.82 million in annual revenue and a reported net income loss of US$8.192 million, placing it among mid cap US healthcare stocks. See our latest analysis for CareDx. Recent...

Aveanna Healthcare Holdings (AVAH) has put fresh earnings in focus after reporting first quarter results, with higher sales and net income than a year earlier and slightly raised full year revenue guidance. See our latest analysis for Aveanna Healthcare Holdings. At a share price of US$7.33, Aveanna has pulled back about 4% over the past week but is still up roughly 12% over 30 days. Its 1 year total shareholder return of about 38% and very large 3 year total shareholder return suggest...

Event context and quick snapshot Texas Capital Bancshares (TCBI) has drawn investor attention after recent trading, with the stock last closing at US$99.39 and showing limited movement over the past month along with a stronger total return profile over the past 3 months and year. See our latest analysis for Texas Capital Bancshares. The recent 1-year total shareholder return of 39.12% and 3-year total shareholder return of 100.67% suggest momentum has been building. This contrasts with the...

In recent months, Citizens Financial Group reported mixed first-quarter results, with revenue roughly matching forecasts, slightly higher net interest income, but tangible book value per share coming in below analyst estimates amid a softer backdrop for regional banks. At the same time, its multiyear "Reimagine the Bank" program, targeting about US$450 million in run-rate efficiency gains, underscores management’s emphasis on reshaping operations and cost structure despite near-term...

Earlier in May 2026, Dynex Capital’s board declared a US$0.17 per-share cash dividend for May, payable on June 1, 2026, to shareholders of record as of May 21, 2026. At the same time, shareholders approved doubling the company’s authorized common shares to 720 million and backed board, compensation, and governance measures, signaling support for Dynex Capital’s evolving capital structure and leadership framework. We will now examine how the doubling of authorized common shares shapes Dynex...

Earlier in May 2026, FTI Consulting appointed Andreas P. Stöcklin to lead its Transactions practice across Continental Europe and named Emanuele Grasso as Senior Managing Director and head of the Corporate Finance segment in Italy, both joining the EMEA management structure to deepen M&A and transaction support capabilities. These hires bring decades of cross-border deal experience and board advisory expertise from firms such as Kroll and PwC, highlighting FTI Consulting’s intent to build...

In recent months, AngloGold Ashanti has faced increased scrutiny as ABSA Securities downgraded the miner, while insiders, including the CEO and a director, sold shares without any offsetting insider purchases. This combination of analyst caution on costs and operations alongside ongoing insider selling raises fresh questions about how management views the company’s current positioning. Now we’ll examine how ABSA’s downgrade, rooted in mining cost inflation and operational risk, may reshape...

Sun Communities (SUI) has drawn investor attention after recent share moves, with the stock up 1.2% over the past day and 5.1% over the past week, despite declines over the past month. See our latest analysis for Sun Communities. The recent 7 day share price return of 5.1% contrasts with more muted year to date gains of 4.6% and a 1 year total shareholder return of 10.2%. This suggests near term momentum is improving from a softer medium term trend. If this move in Sun Communities has you...

Illumina, Inc. has added former Labcorp Executive Chairman and CEO David P. King to its Board of Directors, following the May 21, 2026 annual shareholder meeting and alongside equity grants to several directors as part of their compensation. King’s deep background in large-scale diagnostics businesses and clinical operations underlines Illumina’s push to embed genomics more firmly into everyday medical decision-making as it refreshes its Board. We’ll now examine how King’s board appointment,...

Recent share performance and context Oppenheimer Holdings (OPY) has seen mixed share performance recently, with the stock down about 3% over the past day and roughly 9% over the past month, yet up around 9% in the past 3 months. See our latest analysis for Oppenheimer Holdings. Despite the recent 9% decline in the 1 month share price return to US$93.86, momentum over the year still looks constructive. A 29.21% year to date share price return and a 50.07% 1 year total shareholder return...

In May 2026, MicroVision, Inc. reported first quarter 2026 results, with sales rising to US$935,000 from US$589,000 a year earlier, while net loss narrowed to US$25.29 million and basic loss per share improved to US$0.08 from US$0.12. This combination of higher sales and a smaller loss suggests incremental progress in MicroVision’s efforts to scale its lidar and perception technology business. We'll examine how this early revenue growth and reduced quarterly loss could influence...

Melco Resorts & Entertainment (MLCO) has been drawing attention after a period of weaker share performance, with the stock down over the past month and past 3 months. This has prompted closer scrutiny of its current valuation. See our latest analysis for Melco Resorts & Entertainment. At a latest share price of $5.38, Melco Resorts & Entertainment has seen its 7 day share price return fall 2.71% and its year to date share price return decline 28.36%, while the 5 year total shareholder return...

Why Post Holdings stock is on investors’ radar today Post Holdings (POST) is drawing attention after recent trading left the stock down over the past month and past 3 months, prompting investors to reassess its consumer packaged foods and foodservice footprint. At a recent close of US$97.17 and a market value of about US$4.4b, the company sits in the mid cap range for U.S. food and beverage stocks, with operations spanning cereals, pet food, refrigerated retail products, and foodservice...

Mirum Pharmaceuticals (MIRM) has just completed a zero coupon convertible note offering of $600 million due 2032, a financing move that can reshape its capital structure and influence how investors assess the stock. See our latest analysis for Mirum Pharmaceuticals. Mirum’s recent zero coupon convertible note offering comes after a mixed stretch for the stock, with the share price up 26.32% year to date but down 8.24% over 90 days. The one year total shareholder return of 124.14% and five...

Builders FirstSource previously filed a US$41.62 million shelf registration for 6,050,000 common shares tied to its ESOP and confirmed a planned leadership transition naming Mike Hiller as Chief Operating Officer-designate while appointing Coley O’Brien as Chief Human Resources Officer. This combination of an employee-focused share offering and a long-term succession plan underscores the company’s emphasis on workforce alignment and operational continuity. We’ll now examine how the COO...

Event overview and recent share performance Open Text (NasdaqGS:OTEX) has drawn fresh attention after a period in which the stock is down about 26% year to date and down about 38% over the past 3 years, prompting investors to reassess the business. See our latest analysis for Open Text. Recent price action has been choppy, with a 1 month share price return of 4.73%, a year to date share price return that is down 26.06%, and a 3 year total shareholder return that is down 37.97%, signaling that...

Earlier this month, Driftwood Hospitality Management expanded its use of Flywire’s hospitality payments platform across nearly 90 U.S. hotel properties, digitizing contracts, deposits and multi-channel guest payments while cutting manual processing and fees, particularly through greater ACH adoption. This rollout shows how Flywire’s software-led payments model can reshape operational workflows for large hotel portfolios, pairing cost savings with a more seamless guest experience across major...

In May 2026, Inhibrx Biosciences reported a first-quarter net loss of US$33.44 million, narrower than a year earlier, and released positive interim Phase 2 data from its HexAgon trial of INBRX-106 plus pembrolizumab in first-line PD-L1 positive metastatic or unresectable recurrent head and neck squamous cell carcinoma. The interim data showed a higher confirmed objective response rate and the emergence of complete responses with the INBRX-106 combination, underscoring the potential...